TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Adam Gregory(John Radcliffe Hospital), Lars Fugger(University of Oxford), Finn Cilius Nielsen(University of Copenhagen), Kathrine E. Attfield(University of Oxford), Divya Punwani(MRC Human Immunology Unit), Richard M. Siegel(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Falk Butter(Friedrich-Loeffler-Institut), Aiden Haghikia(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dionysia K. Xifara(University of Oxford), Calliope A. Dendrou(University of Oxford), Simone Prömel(Heinrich Heine University Düsseldorf), James H. Felce(University of Oxford), Oliver Leach(University of Oxford), Ralf Gold(St. Josef-Hospital), Simon J. Davis(University of Oxford), Gereon Poschmann(Düsseldorf University Hospital), Matthias Mann(Max Planck Institute of Biochemistry), John I. Bell(University of Oxford), Gil McVean(Genomics (United Kingdom)), Lydia Lambert(John Radcliffe Hospital), Gurman Kaur(John Radcliffe Hospital)
Cited by 382
Related Papers
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
|Nature Biotechnology|2008|15.7k
The Perseus computational platform for comprehensive analysis of (prote)omics data
|Nature Methods|2016|8.9k
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
|Journal of Proteome Research|2011|5.9k
Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
|Molecular & Cellular Proteomics|2014|5.5k
Detecting Novel Associations in Large Data Sets
|Science|2011|3.4k